73685-55-9

Basic information

• Product Name: N-BENZYL-2-CHLORO-N-ETHYL-ACETAMIDE
• Synonyms: N-BENZYL-2-CHLORO-N-ETHYL-ACETAMIDE;AKOS BBS-00006520;2-chloro-N-ethyl-N-(phenylmethyl)acetamide;2-chloro-N-ethyl-N-(phenylmethyl)ethanamide;ZINC03276935
• CAS NO: 73685-55-9
• Molecular Formula: C11H14ClNO
• Molecular Weight: 211.69
• Mol File: 73685-55-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-BENZYL-2-CHLORO-N-ETHYL-ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: N-BENZYL-2-CHLORO-N-ETHYL-ACETAMIDE(73685-55-9)
• EPA Substance Registry System: N-BENZYL-2-CHLORO-N-ETHYL-ACETAMIDE(73685-55-9)

Safety Data

• Hazardous Substances Data: 73685-55-9(Hazardous Substances Data)

Upstream product

• 14321-27-8 N-ethylbenzylamine 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 1147105-58-5 C₁₅H₂₄NO₄P 
• 1628434-28-5 (S)-1-ethyl-4-phenylazetidin-2-one 

Relevant articles and documents

Palladium-catalyzed olefination of aryl/alkyl halides with trimethylsilyldiazomethane via carbene migratory insertion

The direct olefination of aryl/alkyl halides with trimethylsilyldiazomethane (TMSD) as a C1- or C2-unit was achieved successfully via a metal carbene migratory insertion process, which offered a new access to afford (E)-vinyl silanes and (E)-silyl-substituted α,β-unsaturated amides in good yields and high chemoselectivity.

Interleukin-4 gene expression inhibitors

This invention discloses and claims a class of indole and benzo(b)thiophene derivatives for use in treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections. The compounds of this invention are defined by the Formula (I): wherein X, Y, Z, R1, R2 and R3 are as defined in the specification; or a pharmaceutically acceptable salt thereof. In preferred embodiments of this invention it is also disclosed and claimed that the compounds of this invention are capable of modulating T helper (Th) cells, Th1/Th2, and thereby capable of inhibiting the transcription of interleukin-4 (IL-4) message, IL-4 release or IL-4 production.